Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults.

Saved in:
Bibliographic Details
Title: Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults.
Authors: Madan, Anuradha1 anu.2.madan@gsk.com, Segall, Nathan2, Ferguson, Murdo3, Frenette, Louise4, Kroll, Robin5, Friel, Damien6, Soni, Jyoti7, Ping Li8, Innis, Bruce L.8, Schuind, Anne8, Li, Ping8 (AUTHOR)
Source: Journal of Infectious Diseases. 12/1/2016, Vol. 214 Issue 11, p1717-1727. 11p.
Database: Environment Complete
Description
ISSN:00221899
DOI:10.1093/infdis/jiw414